DE NOVO POINT MUTATIONS and Copy Number Variations CNVs

Friday, May 30, 2008

New Mutations Linked to Sporadic Schizophrenia Advancing Paternal Age

Medical News: Schizophrenia

New Mutations Linked to Sporadic Schizophrenia
By Michael Smith, North American Correspondent, MedPage Today
Published: May 30, 2008
Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. Earn CME/CE credit
for reading medical news




NEW YORK, May 30 -- About 10% of sporadic cases of schizophrenia appear to arise from spontaneous genetic mutations not inherited from either parent, researchers here said.

So-called copy number variants were seen in 15 of 152 patients with the disease but not in their unaffected parents, according to Maria Karayiorgou, M.D., of Columbia, and colleagues.

In contrast, such uninherited variants were only seen in two of 159 unaffected controls, Dr. Karayiorgou and colleagues reported online in Nature Genetics.

"We now know the cause of around 10% of the cases of sporadic schizophrenia," Dr. Karayiorgou added. Action Points
--------------------------------------------------------------------------------

Explain to interested patients that schizophrenia affects about 1% of the population, with 40% being inherited while the other 60% appeared sporadically in people without a family history of the disease.


Note that this study suggests that new genetic mutations -- copy number variants -- are significantly associated with sporadic cases of the disease and may account for about 10% of cases.
The findings mean that "schizophrenia is not as much of a 'big black box' as it used to be," Dr. Karayiorgou said.


Abnormal deletions or duplications of genetic material "are increasingly being implicated in schizophrenia and autism," said Thomas Insel, M.D., director of the National Institute of Mental Health, which was one of the supporters of the research.


"Now we have a dramatic demonstration that genetic vulnerabilities for these illnesses may stem from both hereditary and non-hereditary processes," Dr. Insel said in a statement.


The research "holds promise for improved treatments -- and perhaps someday even prevention -- of developmental brain disorders," he added.


The researchers carried out a whole-genome scan of 1,077 volunteers from a genetically homogenous Afrikaner population in South Africa, including 152 patients with sporadic schizophrenia, 159 controls, 48 people with familial schizophrenia, and both biological parents in all cases.


In the first step, the researchers used microarray technologies to identify copy number variation -- either gains or losses from the parental genome -- among the sporadic cases and the controls.


They identified 19 copy number variations, including 11 gains and eight losses, among the 15 cases and two controls.


The variants were roughly eight times as common among the cases as among the unaffected controls, Dr. Karayiorgou and colleagues said, and the association with schizophrenia was significant at P=0.00078, using a two-tailed Fisher's exact test.


Among the 48 volunteers with familial schizophrenia, there were no spontaneous copy number variations, implying that the association is "primarily confined to the sporadic cases," the researchers said.


On the other hand, when the researchers looked at rare inherited copy number mutations among the sporadic cases and controls, they found little difference. Thirty percent of the cases carried such a mutation compared with 20% of the controls.


Dr. Karayiorgou and co-workers have previously shown that loss of genes on chromosome 22, in the region 22q11.2, is responsible for introducing sporadic cases of schizophrenia into the population.


In the current study, three of the copy number variations found among sporadic cases occurred in that region, the researchers said, and all involved loss of function.


One possibility is that the identification of the mutated genes will allow researchers to discern the brain-development pathways that are involved in disease onset, "so that in the future we can look at better ways of treating this devastating disease," she said.


The study was supported by the National Institute of Mental Health and the Lieber Center for Schizophrenia Research at Columbia University Medical Center. The microarray experiments were carried out in the Vanderbilt Microarray Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center, the Vanderbilt Digestive Disease Center, and the Vanderbilt Vision Center. Dr. Karayiorgou did not report any potential conflicts.



Primary source: Nature Genetics
Source reference:
Xu B, et al "Strong association of de novo copy number mutations with sporadic schizophrenia" Nature Genetics 2008; DOI:10.1038/ng.162.

Additional Schizophrenia Coverage

Earn CME/CE credit
for reading medical news



Add Your Knowledge™

Contribute your own thoughts, experience, questions, and knowledge to this story for the benefit of all MedPage Today readers.




Disclaimer



To our readers:
"Add Your Knowledge" is a chance to provide your point of view on the medical science presented in these articles, based on your clinical experience or your interest in the area. Your comments may be edited for space.

Mark Bloom
Editor-in-Chief

Labels:

Saturday, May 3, 2008

It is also recognized that paternal age is increased among affected children."

1: Nat Rev Genet. 2008 May;9(5):341-55. Links
Advances in autism genetics: on the threshold of a new neurobiology.Abrahams BS, Geschwind DH.
Neurology Department, and Semel Institute for Neuroscience and Behaviour, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095-1769 USA. brett.abrahams@gmail.com


Autism is a heterogeneous syndrome defined by impairments in three core domains: social interaction, language and range of interests. Recent work has led to the identification of several autism susceptibility genes and an increased appreciation of the contribution of de novo and inherited copy number variation. Promising strategies are also being applied to identify common genetic risk variants. Systems biology approaches, including array-based expression profiling, are poised to provide additional insights into this group of disorders, in which heterogeneity, both genetic and phenotypic, is emerging as a dominant theme.

PMID: 18414403 [PubMed - in process]

Labels:


Photarium blog directory Blog Directory - photarium